Author
Listed:
- Jiyeon Kim
(UT Southwestern Medical Center)
- Zeping Hu
(UT Southwestern Medical Center)
- Ling Cai
(UT Southwestern Medical Center)
- Kailong Li
(UT Southwestern Medical Center)
- Eunhee Choi
(UT Southwestern Medical Center)
- Brandon Faubert
(UT Southwestern Medical Center)
- Divya Bezwada
(UT Southwestern Medical Center)
- Jaime Rodriguez-Canales
(University of Texas MD Anderson Cancer Center)
- Pamela Villalobos
(University of Texas MD Anderson Cancer Center)
- Yu-Fen Lin
(UT Southwestern Medical Center)
- Min Ni
(UT Southwestern Medical Center)
- Kenneth E. Huffman
(UT Southwestern Medical Center)
- Luc Girard
(UT Southwestern Medical Center)
- Lauren A. Byers
(University of Texas MD Anderson Cancer Center)
- Keziban Unsal-Kacmaz
(Oncology Research Unit)
- Christopher G. Peña
(UT Southwestern Medical Center
University of Texas Health Science Center San Antonio)
- John V. Heymach
(University of Texas MD Anderson Cancer Center)
- Els Wauters
(University of Gasthuisberg, KU Leuven)
- Johan Vansteenkiste
(University of Gasthuisberg, KU Leuven)
- Diego H. Castrillon
(UT Southwestern Medical Center)
- Benjamin P. C. Chen
(UT Southwestern Medical Center)
- Ignacio Wistuba
(University of Texas MD Anderson Cancer Center)
- Diether Lambrechts
(KU Leuven
KU Leuven)
- Jian Xu
(UT Southwestern Medical Center)
- John D. Minna
(UT Southwestern Medical Center)
- Ralph J. DeBerardinis
(UT Southwestern Medical Center
UT Southwestern Medical Center
UT Southwestern Medical Center)
Abstract
Further analysis has revealed that the signal reported in Extended Data Fig. 1c of this Letter is attributed to phosphorylethanolamine, not carbamoyl phosphate. A newly developed derivatization method revealed that the level of carbamoyl phosphate in these NSCLC extracts is below the detection threshold of approximately 10 nanomoles. These findings do not alter the overall conclusions of the Letter; see associated Amendment for full details. The Letter has not been corrected online.
Suggested Citation
Jiyeon Kim & Zeping Hu & Ling Cai & Kailong Li & Eunhee Choi & Brandon Faubert & Divya Bezwada & Jaime Rodriguez-Canales & Pamela Villalobos & Yu-Fen Lin & Min Ni & Kenneth E. Huffman & Luc Girard & L, 2019.
"Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells,"
Nature, Nature, vol. 569(7756), pages 4-4, May.
Handle:
RePEc:nat:nature:v:569:y:2019:i:7756:d:10.1038_s41586-019-1133-3
DOI: 10.1038/s41586-019-1133-3
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:569:y:2019:i:7756:d:10.1038_s41586-019-1133-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.